Revolution Medicines, Inc. (RVMD) Reports Q1 Loss of $1.13

Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q1 EPS of ($1.13), versus ($1.09) reported last year.

For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Jefferies Starts Louisiana-Pacific Corp (LPX) at Buy
• Micron Technology (MU) call put ratio 1 call to 1 put into quarter results